Page last updated: 2024-10-25

dantrolene and Uterine Neoplasms

dantrolene has been researched along with Uterine Neoplasms in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Uterine Neoplasms: Tumors or cancer of the UTERUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, L1
Au-Yeung, CL1
Huang, C1
Yeung, TL1
Ferri-Borgogno, S1
Lawson, BC1
Kwan, SY1
Yin, Z1
Wong, ST1
Thomas, V1
Lu, KH1
Yip, KP1
Sham, JSK1
Mok, SC1

Other Studies

1 other study available for dantrolene and Uterine Neoplasms

ArticleYear
Ryanodine receptor 1-mediated Ca
    Journal of experimental & clinical cancer research : CR, 2022, Aug-11, Volume: 41, Issue:1

    Topics: Animals; Cystadenocarcinoma, Serous; Dantrolene; Female; Humans; Mice; Phenotype; Proto-Oncogene Pro

2022